Temozolomide and Tumor - a phase IV clinical study of FDA data

Summary:

Tumor is reported as a side effect among people who take Temozolomide (temozolomide), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Sandostatin, and have Neuroendocrine tumor.

The phase IV clinical study analyzes which people have Tumor when taking Temozolomide. It is created by eHealthMe based on reports of 16,598 people who have side effects when taking Temozolomide from the FDA, and is updated regularly.

What is Temozolomide?

Temozolomide has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 16,644 Temozolomide users. Check the latest studies of Temozolomide.

What is Tumor?

Tumor is found to be associated with 1,405 drugs and 1,707 conditions by eHealthMe. Check the latest studies of Tumor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 06, 2026

16,598 people reported to have side effects when taking Temozolomide.
Among them, 83 people (0.5%) have Tumor.

Could Temozolomide cause Tumor?

Among these 83 people:

How long have people been on Temozolomide when they have Tumor? *

  • < 1 month: 12.5 %
  • 1 - 6 months: 62.5 %
  • 6 - 12 months: 12.5 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 12.5 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Tumor when taking Temozolomide? *

  • female: 70.18 %
  • male: 29.82 %

What is the age of people who have Tumor when taking Temozolomide? *

  • 0-1: 6.67 %
  • 2-9: 15.56 %
  • 10-19: 2.22 %
  • 20-29: 0.0 %
  • 30-39: 4.44 %
  • 40-49: 11.11 %
  • 50-59: 40.0 %
  • 60+: 20.0 %

What are other drugs people take besides Temozolomide? *

  1. Sandostatin: 42 people, 50.60%
  2. Pancreatin: 38 people, 45.78%
  3. Lactobacillus: 34 people, 40.96%
  4. Gammagard: 9 people, 10.84%
  5. Probiotics: 4 people, 4.82%
  6. Cotazym: 4 people, 4.82%
  7. Avastin: 3 people, 3.61%
  8. Everolimus: 3 people, 3.61%
  9. Lactobacillus Acidophilus: 3 people, 3.61%
  10. Nexium: 3 people, 3.61%

What are other side effects people have besides Tumor? *

  1. Headache (pain in head): 53 people, 63.86%
  2. High Blood Pressure: 49 people, 59.04%
  3. Fatigue (feeling of tiredness): 48 people, 57.83%
  4. Fever: 47 people, 56.63%
  5. Malaise (a feeling of general discomfort or uneasiness): 46 people, 55.42%
  6. Malignant Neoplasm Progression (cancer tumour came back): 46 people, 55.42%
  7. Diarrhea: 45 people, 54.22%
  8. Nausea (feeling of having an urge to vomit): 45 people, 54.22%
  9. Nausea And Vomiting: 44 people, 53.01%
  10. Chills (felling of cold): 44 people, 53.01%

What are the existing conditions these people have? *

  1. Neuroendocrine Tumor: 45 people, 54.22%
  2. Flatulence (flatus expelled through the anus): 14 people, 16.87%
  3. Brain Neoplasm Malignant (brain cancer tumour): 11 people, 13.25%
  4. Malignant Glioma (cancerous tumour of brain a cancer tumour of uncertain origin that arises both in soft tissue and bone): 3 people, 3.61%
  5. Pancreatic Carcinoma (pancreatic cancer): 2 people, 2.41%
  6. Rhabdoid Tumor Of The Kidney: 2 people, 2.41%
  7. Metastatic Glioma (spreadable cancer tumour of brain): 2 people, 2.41%
  8. Optic Glioma (optic disc tumour): 2 people, 2.41%
  9. Brain Neoplasm (tumour of brain): 2 people, 2.41%
  10. Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 1.20%

* Approximation only. Some reports may have incomplete information.

Do you take Temozolomide and have Tumor?

- Check whether Tumor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temozolomide:

Tumor treatments and more:

How severe was Tumor and when was it recovered:

Expand to all the drugs that have ingredients of temozolomide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temozolomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tumor:

Browse all the conditions that are associated with Tumor:

  • Tumor (1,707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temozolomide (the active ingredients of Temozolomide) and Temozolomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: